Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Neli Boneva
Observed name:
N Boneva
Institution:
Lundbeck (Denmark)
Observed institutions:
Centre National de la Recherche Scientifique,
Lundbeck (Denmark),
Hebrew University of Jerusalem,
Hadassah Medical Center,
Hospital Clínic de Barcelona,
Hôpital Marie Lannelongue
show all 6
OpenAlex ID:
A5011041823
Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease: Three Randomized Clinical Trials
2018
·
Alireza Atri
, Lutz Frölich
, et al.
·
JAMA
·
175
PDF
The role of readthrough acetylcholinesterase in the pathophysiology of myasthenia gravis
2003
·
Talma Brenner
, Yasmine Hamra‐Amitay
, et al.
·
The FASEB Journal
·
121
A randomized, double-blind, placebo-controlled trial of memantine in a behaviorally enriched sample of patients with moderate-to-severe Alzheimer's disease
2013
·
Nathan Herrmann
, Serge Gauthier
, et al.
·
International Psychogeriatrics
·
60
Major pathogenic effects of anti-MuSK antibodies in Myasthenia Gravis
2006
·
Neli Boneva
, Melinee Frenkian-Cuvelier
, et al.
·
Journal of Neuroimmunology
·
49
Gabapentin may be hazardous in myasthenia gravis
2000
·
Neli Boneva
, Talma Brenner
, et al.
·
Muscle & Nerve
·
47
Enrichment factors for clinical trials in mild‐to‐moderate Alzheimer's disease
2019
·
Clive Ballard
, Alireza Atri
, et al.
·
Alzheimer s & Dementia Translational Research & Clinical Interventions
·
36
PDF
Efficacy and Safety of Eptinezumab in Episodic Cluster Headache: A Randomized Clinical Trial
2025
·
Rigmor H. Jensen
, Cristina Tassorelli
, et al.
·
JAMA Neurology
·
24
PDF
Insights into globalization: comparison of patient characteristics and disease progression among geographic regions in a multinational Alzheimer’s disease clinical program
2018
·
Jeffrey L. Cummings
, Alireza Atri
, et al.
·
Alzheimer s Research & Therapy
·
22
PDF
Long-term safety, tolerability, and efficacy of eptinezumab in chronic cluster headache (CHRONICLE): an open-label safety trial
2025
·
Cristina Tassorelli
, Rigmor H Jensen
, et al.
·
The Lancet Neurology
·
16
Open-Label, Multicenter, Phase III Extension Study of Idalopirdine as Adjunctive to Donepezil for the Treatment of Mild-Moderate Alzheimer’s Disease
2019
·
Lutz Frölich
, Alireza Atri
, et al.
·
Journal of Alzheimer s Disease
·
15
Stimulated-single fiber electromyography monitoring of anti-sense induced changes in experimental autoimmune myasthenia gravis
2006
·
Neli Boneva
, Yasmine Hamra-Amitay
, et al.
·
Neuroscience Research
·
11
Gabapentin May Be Hazardous in Myasthenia Gravis
1999
·
N Boneva
, T Brenner
, et al.
·
Topics in Pain Management
·
2
ALLEVIATE, a Clinical Trial-in-Progress of Eptinezumab in Patients With Episodic Cluster Headache (P3-2.002)
2022
·
Stewart J. Tepper
, Neli Boneva
, et al.
·
Neurology
·
1
P3‐003: Identifying Enrichment Factors That Predict Alzheimer's Disease Progression: an Analysis of Three Randomized, Controlled Trials
2018
·
Clive Ballard
, Alireza Atri
, et al.
·
Alzheimer s & Dementia
[DT‐02–02]: IDALOPIRDINE, A 5‐HT6 ANTAGONIST, AS ADJUNCTIVE THERAPY TO ACETYLCHOLINESTERASE INHIBITORS IN PATIENTS WITH MILD‐MODERATE ALZHEIMER's DISEASE: KEY OUTCOMES FROM THE STAR PHASE III PROGRAM
2017
·
Alireza Atri
, Lutz Frölich
, et al.
·
Alzheimer s & Dementia
P1‐056: Idalopirdine, A 5‐HT6 Antagonist in Phase III Development as Adjunctive Therapy to Cholinesterase Inhibitors in Patients with Mild‐to‐Moderate Alzheimer’s Disease: Baseline Data from the Ongoing Starshine Study
2016
·
Alireza Atri
, Neli Boneva
, et al.
·
Alzheimer s & Dementia
Show more works
View as search
Works count:
18
Citation count:
579
H-index:
11
I10-index:
11
Year
Topic
Type